Regeneron Buys 23andMe, User Data for $256M
Regeneron acquires 23andMe for $256M, gaining access to genetic data to support its push into personalized medicine and biotech innovation…
23andMe’s Future Sparks Concerns Over Genomic Data
A New York Times article indicates that customers of the genetic data company 23andMe might face greater risks than they are aware of The…